MIRNA CHEHADE, MD
Associate Professor of Pediatrics and Medicine Director, Mount Sinai Center for Eosinophilic Disorders Icahn School of Medicine at Mount Sinai New York, New York
IKUO HIRANO, MD
Professor of Medicine (Gastroenterology and Hepatology) Northwestern University Feinberg School of Medicine Chicago, Illinois
JONATHAN SPERGEL, MD
Chief, Allergy Program, Children’s Hospital of Philadelphia Stuart E. Starr Chair of Pediatrics Professor of Pediatrics Perelman School of Medicine, University of Pennsylvania Philadelphia, Pennsylvania
LEARNING OBJECTIVES After completing of this activity, participants will be better prepared to: • Describe the pathophysiologic mechanisms underlying EoE development, with a focus on potential therapeutic targets • Comprehensively assess pediatric and adult patients with suspected EoE to accelerate differential diagnoses and establish appropriate multidisciplinary care
Americans with Disabilities Act Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Integritas prior to the live event at info@ exchangecme.com. There is no registration fee for attending this NonCME Corporate Forum; however, seating is limited. Preregistration does not guarantee seating. We recommend arriving at the meeting room early.
• Longitudinally manage pediatric and adult patients with EoE based on symptoms, comorbidities, updated clinical guidelines, and therapeutic responses
This activity is supported by an independent grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
• Communicate with patients, caregivers, and members of the multidisciplinary team to ensure continuity of care and promote shared clinical decision-making
The Non-CME Corporate Forum content and views expressed therein do not necessarily reflect the views, policies or position of the American College of Allergy, Asthma & Immunology.
• Compare the clinical profiles, available trial evidence, and drawbacks of current and emerging treatment strategies for EoE